Yes, though "allergy" is doing loose work in that sentence. You cannot be allergic to smoke itself, because smoke is not a single substance. You can be allergic to specific proteins in the fuel that produce it, and you can mount allergy-like immune reactions to smoke's chemical payload. Most people who react to wood smoke have irritant or non-IgE hypersensitivity, not a true immunoglobulin E allergy. The distinction matters because it changes what helps, what tests mean, and how much exposure you can realistically tolerate.

What smoke actually contains

Smoke is an aerosol: solid particles, liquid droplets, and gases suspended in air, produced when fuel burns incompletely. The particle fraction carries most of the mass and most of the health relevance. Fine particles under 2.5 micrometers in diameter (PM2.5) penetrate deep into the alveoli, and ultrafine particles under 0.1 micrometers can cross into the bloodstream. Wood smoke PM2.5 is largely carbon-centered soot coated with organic compounds.

The gas phase includes carbon monoxide, nitrogen oxides, sulfur dioxide, formaldehyde, acrolein, benzene, and polycyclic aromatic hydrocarbons (PAHs). Acrolein and formaldehyde are potent mucosal irritants at parts-per-million concentrations. PAHs are carcinogenic and also act as adjuvants, meaning they can amplify immune responses to whatever else is present. This is the first mechanistic clue: an adjuvant-rich aerosol makes bystander proteins more likely to trigger sensitization.

The protein question

True allergy requires an allergen, usually a protein or glycoprotein, that cross-links IgE antibodies on mast cells. Smoke from pure combustion of cellulose and lignin does not contain intact proteins. But real fires are not pure. Wood carries mold spores, pollen, insect fragments, and microbial proteins. Wildland fire smoke entrains soil, plant debris, and fungal material. Cigarette smoke is a separate case: it contains tobacco-specific glycoproteins and can induce IgE against them in some smokers. So the honest answer is that whether smoke can be an allergen depends on what is burning and what it lofted into the plume.

How immune and irritant mechanisms diverge

IgE-mediated allergy is a two-step process. First, an antigen-presenting cell introduces the protein to a T helper 2 cell, which instructs B cells to class-switch toward IgE. That IgE binds FcεRI receptors on mast cells and basophils. On re-exposure, allergen cross-links adjacent IgE, triggering degranulation within minutes: histamine, tryptase, leukotrienes, prostaglandins. This produces the classic immediate wheeze, hives, and rhinorrhea, and it is what skin-prick and specific-IgE blood tests detect.

Non-IgE irritant mechanisms are different and, for smoke, more common. Smoke chemicals activate transient receptor potential channels, especially TRPA1 and TRPV1, on sensory nerve endings in the airway and conjunctiva. This triggers neurogenic inflammation: substance P and CGRP release, local edema, cough, and reflex bronchoconstriction. Acrolein activates TRPA1 at low micromolar concentrations. This pathway needs no prior sensitization, which is why a first-ever wildfire exposure can cause symptoms. It also explains why symptoms track exposure intensity rather than a threshold allergy dose.

A third mechanism is mixed and slower. Repeated smoke exposure recruits neutrophils and raises IL-8 in the airway, producing an irritant-induced asthma phenotype sometimes called reactive airways dysfunction syndrome when it follows a single high-dose event. In wildfire firefighters, cohort studies document persistent airway hyperresponsiveness years after season-end, consistent with remodeling rather than allergy.

Plain language: true allergy is a lock-and-key immune misfire set off by a protein, while smoke mostly jimmies the lock with chemistry and nerve irritation.

Quantified context and exposure thresholds

The most useful number in smoke exposure is PM2.5 concentration, reported in micrograms per cubic meter (µg/m³). The US Environmental Protection Agency's Air Quality Index maps PM2.5 to six categories. The table below reconciles the AQI bands with the health meanings people actually use.

AQI category PM2.5 (µg/m³, 24-hour) Who is typically affected Practical read
Good (0–50) 0.0–9.0 Essentially no one Baseline
Moderate (51–100) 9.1–35.4 Unusually sensitive people Sensitive groups may notice symptoms
Unhealthy for sensitive groups (101–150) 35.5–55.4 Asthma, COPD, heart disease, children, older adults Reduce prolonged outdoor exertion
Unhealthy (151–200) 55.5–150.4 Everyone may begin to feel effects Move activity indoors
Very unhealthy (201–300) 150.5–250.4 All groups, more serious Stay indoors, filter air
Hazardous (301+) 250.5+ Emergency-level risk Shelter and filtration mandatory

For scale, a typical campfire at close range can expose you to several hundred to over a thousand µg/m³ of PM2.5 in the immediate plume, easily surpassing Hazardous. A wildfire plume 50 kilometers downwind can still deliver 40–100 µg/m³. Cigarette sidestream smoke near a smoker runs in the hundreds of µg/m³. And a single incense stick in a small closed room can push PM2.5 above 100 µg/m³ within minutes, which surprises people who consider incense benign.

Carbon monoxide is the other fast-moving hazard indoors. A charcoal grill or generator used in a garage or tent can raise CO to hundreds of parts per million, which is lethal within hours. CO binds hemoglobin with roughly 200–250 times the affinity of oxygen, so even low concentrations displace oxygen delivery. This is a poisoning problem, not an allergy problem, and it deserves its own urgency.

Edge cases that complicate the label

Several populations and scenarios blur the allergy-versus-irritation boundary. Children have higher minute ventilation per kilogram of body weight, so they inhale more smoke per unit mass than adults doing the same activity. Their airways are also smaller in absolute caliber, so a given amount of mucosal swelling produces more resistance. Pregnant people face added concern because PM2.5 crosses the placenta and has been associated with adverse birth outcomes in wildfire cohorts.

People with pre-existing asthma or allergic rhinitis often report that smoke "triggers my allergies." In most cases this is bronchial hyperresponsiveness and neural irritation layered on top of their existing disease, not new sensitization. A minority have genuine IgE to mold or pollen borne on smoke. Distinguishing them requires history and testing, not assumption.

There is a genuinely counterintuitive edge case: some individuals with mast cell activation disorders or chronic urticaria react to smoke with hives and flushing without any detectable specific IgE. Their mast cells are hyperreactive to non-immune triggers including heat, chemical irritants, and stress. Smoke can provoke degranulation directly. This presents as allergy but is not classical allergy, and antihistamines may help symptomatically while tests stay negative.

Another caveat from occupational medicine: firefighters and wildland crews show elevated rates of irritant-induced asthma and rhinosinusitis, but their allergy rates to smoke constituents are not clearly elevated. The dose-response is irritant, not immunologic. That is an important professional distinction, because it argues for exposure control rather than allergen avoidance strategies.

Red-flag warnings requiring medical evaluation

Stridor, throat tightness, or voice change after smoke exposure Chest pain, palpitations, or syncope with smoke inhalation Confusion, headache with nausea, or anyone found drowsy near a fire or generator (suspect carbon monoxide) Wheeze that does not improve with prescribed rescue medication, or peak flows falling below your personal action threshold Soot in the mouth or nose with hoarseness after a fire, suggesting airway burn Symptoms in an infant, pregnant person, or someone with known heart disease at AQI above 150

Misconceptions worth correcting

The most common misconception is that a negative allergy test rules out smoke sensitivity. Skin-prick panels test for a fixed list of proteins, usually pollens, molds, dander, and foods. They do not test for acrolein, formaldehyde, or PAHs, and no validated test exists for irritant sensitivity. A negative panel means you lack IgE to the tested allergens, nothing more.

A second misconception is that masks solve smoke. Cloth and surgical masks reduce large droplets but poorly filter PM2.5. An N95 or KN95, fit-tested, filters at least 95 percent of particles at 0.3 micrometers under test conditions, but facial seal is everything and is often poor on children or bearded faces. Masks also do nothing for carbon monoxide, which passes straight through filter media. A third misconception is that indoor air is safe by default. Without filtration or sealing, indoor PM2.5 during a heavy smoke event can reach 50–70 percent of outdoor levels.

A fourth is that "natural" smoke is safer than industrial smoke. Wood smoke contains many of the same carcinogens as tobacco smoke, including benzene and benzo[a]pyrene, and the World Health Organization classifies wood smoke as a known human carcinogen mixture. The dose differs enormously, but the hazard class does not.

Finally, people assume allergies are permanent. IgE sensitization can wane with avoidance, and irritant sensitivity is not an immune memory phenomenon at all. Someone who reacts badly this fire season may not react identically next season. Conversely, repeated high-dose exposure can worsen reactivity over time.

Practical actions with thresholds

The steps below are sequenced by evidence strength and practicality, using the AQI bands above as the decision points.

Check PM2.5, not the visible haze. Use a local sensor or the AirNow feed. At AQI 101–150, sensitive groups should shorten outdoor exertion; at 151 and above, everyone should move exercise indoors. Seal and filter your indoor space. Close windows and doors, set HVAC to recirculate, and run a HEPA purifier sized for the room. A purifier rated for the room's square footage with a clean filter can cut indoor PM2.5 by 50–80 percent within an hour in a closed room. Build a clean room. Choose one bedroom, filter it aggressively, and sleep there. Overnight exposure matters disproportionately because you spend seven or more hours in one place. Wear an N95 or KN95 only when you must go out, and fit-check it. If it leaks at the nose bridge, it is not protecting you at the stated efficiency. Use CO alarms wherever any combustion occurs indoors or in attached garages, and never run generators, grills, or camp stoves inside. CO alarms are set to sound at 70 ppm after 60–240 minutes or at 150–220 ppm sooner, depending on the standard and model, and those thresholds are calibrated to prevent poisoning. For known IgE-mediated allergy to mold or pollen in smoke, pre-treat with prescribed antihistamines before exposure and keep rescue inhalers accessible. Do not start new medications without a clinician.

Reconciling the thresholds: the AQI bands are 24-hour averages, while acute symptoms follow hourly peaks, so a Good daily average can hide a brutal two-hour spike. Peak-hour readings and personal symptom logs should override the daily number for people with reactive airways. Similarly, HEPA efficiency numbers assume a sealed room and clean filter; leaky windows and a clogged filter can cut real-world performance roughly in half.

Limits of the evidence and what remains unknown

The mechanistic picture for irritant pathways is solid, but human data on smoke allergy specifically are thin. Most wildfire epidemiology measures asthma exacerbations, emergency visits, and cardiovascular events, not incident sensitization. We lack large prospective cohorts that skin-test people before and after wildfire seasons. Claims that smoke "causes allergies" are therefore inferential, not established.

Dose thresholds for individual susceptibility are not well defined. Two people at the same AQI can have wildly different responses based on airway caliber, atopy, age, and genetics. No biomarker currently predicts who will develop irritant-induced asthma after a high-dose exposure, and reactive airways dysfunction syndrome remains a clinical diagnosis of exclusion.

Long-term outcomes of repeated seasonal exposure are still being characterized. The best occupational cohorts suggest persistent hyperresponsiveness and accelerated lung function decline in some firefighters, but generalizing to residents of smoke-prone regions requires caution. Also unresolved: how much protection residential filtration actually delivers against the ultrafine fraction, and whether filtration meaningfully changes clinical outcomes rather than just indoor particle counts.

Finally, the field lacks standardized terminology. "Smoke allergy" is used colloquially for at least three distinct phenomena: IgE to smoke-borne proteins, irritant-triggered asthma, and mast cell hyperreactivity. Until the terminology sharpens, the most useful approach is to identify which mechanism fits your symptoms and exposure pattern, measure your environment, and treat the mechanism rather than the word.